跳至主要内容
临床试验/NL-OMON53965
NL-OMON53965招募中3 期

Hyperbaric Oxygen Therapy for Pyoderma gangrenosum As a New Treatment Strategy - HOT PANTS

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Confirmed consensus on the diagnosis pyoderma gangrenosum by referring
  • specialist, principal and coordinating investigator (dermatologist, clinical
  • immunologist or rheumatologist based on PARACELSUS and Delphi score).
  • - Unsatisfactory response after six weeks of combined standard wound care and
  • systemic prednisone and/or other anti-inflammatory therapy.
  • - Fit for hyperbaric oxygen therapy as assessed by the hyperbaric physician.
  • - Age >=18 years at baseline
  • - All genders
  • - Able and willing to give written informed consent and to comply with the
  • study requirements.

排除标准

  • Language barrier
  • Unable to give informed consent
  • - Pregnancy

研究者

相似试验